二十五年:费克索芬纳丁的临床经验
Robert M Naclerio1, Ignacio J Ansotegui2, Giorgio Walter Canonica3,4
1John Hopkins School of Medicine, Department of Otolaryngology-Head and Neck Surgery USA.
The World Allergy Organization journal
|September 10, 2024
概括
费克索芬纳丁 (FEX) 可以有效地治疗过敏性鼻炎和疹,而不会引起昏昏欲睡. 临床试验数据证实,FEX通过其有利的安全概况改善了患者的生活质量.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏性鼻炎 (AR) 和疹是影响全球生活质量和医疗保健成本的常见疾病.
- 目前的管理需要安全有效的治疗方法,提供快速,持续的症状缓解,无需镇静.
研究的目的:
- 评估fexofenadine (FEX) 作为AR和疹的综合治疗方法.
- 评估FEX在过敏性疾病管理中的有效性,安全性和对生活质量的影响.
主要方法:
- 对费克索芬纳丁 (FEX) 随机临床试验数据的审查.
- 对FEX抗素和抗炎性质的评估.
- 对FEX的安全性概况的评估,包括不同剂量的镇静作用.
主要成果:
- 费克索芬纳丁 (FEX) 在治疗过敏性鼻炎和疹方面表现出显著的疗效.
- 即使在较高剂量中,FEX也表现出良好的安全性,没有相关的镇静作用.
- 临床数据表明,FEX可以改善过敏患者的生活质量.
结论:
- 费克索芬纳丁 (FEX) 是一种安全有效的非镇静抗胰岛素,用于治疗过敏性鼻炎和疹.
- 菲克斯符合理想抗过敏配方的标准,提供快速,持久的症状缓解.
- 费克斯的安全性和疗效的良好概况支持其在改善患者过敏疾病的治疗结果方面的作用.
相关概念视频
Upper Respiratory Drugs: First and Second-Generation Antihistamines
223
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
223
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
103
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
103
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K


